Drug Shortage Report for FETZIMA

Last updated on 2019-06-07 History
Report ID 84776
Drug Identification Number 02440970
Brand name FETZIMA
Common or Proper name FETZIMA 20MG 30 CA
Company Name ALLERGAN INC
Active Ingredient(s) LEVOMILNACIPRAN
Strength(s) 20MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size FETZIMA 20MG 30 CA
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-05-24
Actual start date 2019-05-24
Estimated end date 2019-06-05
Actual end date 2019-06-06
Shortage status Resolved
Updated date 2019-06-07
Company comments Potential issue with the label
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-06-07 English Compare
v6 2019-06-06 French Compare
v5 2019-06-06 English Compare
v4 2019-05-27 French Compare
v3 2019-05-27 English Compare
v2 2019-05-25 French Compare
v1 2019-05-25 English Compare